Method for treating a disease or condition responsive to opening of C1C-2 channel
AssigneeSucampo AG
InventorRyuji Ueno
Life of this patent
Estimating the term…
Abstract
Disclosed is a method for prophylactic or therapeutic treatment of a condition or disease responsive to opening of ClC-2 channel, which comprises the step of administrating an effective amount of a ClC-2 channel opener to a subject in need of said treatment. According to the invention, a tissue or organ to be transplanted can also be treated with the ClC-2 channel opener.
Claims7
A method for therapeutic treatment of digestive system disorder, which comprises the step of administrating an effective amount of a compound selected from the group consisting of 13,14-dihydro-15-keto-16,16-difluoro prostaglandin E1 and 13,14-dihydro-15-keto-16,16-difluoro-18(S)-methyl-prostaglandin E1 to a subject in need of said treatment, wherein the digestive system disorder is gastric ulcer or ulcer in the bowel.
A method for therapeutic treatment of pancreatitis, which comprises the step of administrating an effective amount of 13,14-dihydro-15-keto-16,16-difluoro-18(S)-methyl-prostaglandin E1 to a subject in need of said treatment.
Dependencies are inferred from the claim text.